|Duration: 2 hours (the average time to complete the training program, including final assessments).
Credits Hours: 2
Self-paced Training: 24/7 access to course.
Enrollment Period: 3 months.
Demonstration: Try one of our FREE courses.
Certificate: View sample certificate.
THIS COURSE IS CURRENTLY NOT AVAILABLE.
Contact the BioPharma Institute for more information.
Training Program: Pharmaceutical Regulatory Affairs: Orphan Drug Application – EU and US
Training Provided By: BioPharma Institute
Availability: Immediately available upon ordering.
Description: Online training with immediate access upon enrollment. Orphan drugs are those for relatively rare indications. Special procedures and incentives apply to their registration, to encourage pharmaceutical companies to develop them. This online course provides information necessary to enable the preparation of applications for orphan drug status in the EU and USA. The procedures for making an application are detailed, including the collection of supporting data and the acquisition of protocol assistance. In Europe the Centralized Procedure is now the mandatory route to gain marketing authorization for orphan products. This online course will serve as a useful reference tool to keep abreast of the impact of the new regulatory requirements.
Certification Requirements: Students must view the entire program and successfully pass an online, multiple-choice final assessment with >80% passing grade within a 90 day period of time (180 days for Professional Certification Programs). Certificate is accessible in PDF format immediately after satisfying requirements.
Online Training Programs Include:
The Pharmaceutical Regulatory Affairs: Orphan Drug Application – EU and US course is found in the following professional certification program(s):
Introduction: This session looks at issues which have to be considered when developing Orphan Products in the EU and USA, including the costs of development, development risks, advantages of orphan status, how to obtain advice and strategy for orphan applications.
Students completing this course should be able to: Describe the advantages of orphan drug status in the EU and USA. Explain how to prepare applications for orphan drug designation in the EU and USA. Understand the approval process for orphan designation in the EU and USA and how to proceed if orphan designation is refused.
For more information on the BioPharma Institute’s training programs, or to suggest a course, please complete the form located below. Alternatively, you may call toll free in the US: (888) 4-BIO-LRN, international callers can dial (201) 301-8370, or email Support@BioPharmaInstitute.com.